Showing results (221-230 of 278) with videos related to

Sort By:
Pageof 28
Atherosclerosis|October 7, 2011
Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritisMichelle J Ormseth, Larry L Swift, Sergio Fazio, et al.
NPJ Digital Medicine|February 27, 2024
Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validationChao Yan, Monika E Grabowska, Alyson L Dickson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical DatasetsChao Yan, Monika E Grabowska, Alyson L Dickson, et al.
Annals of the Rheumatic Diseases|September 22, 2020
Circulating microbial small RNAs are altered in patients with rheumatoid arthritisMichelle J Ormseth, Qiong Wu, Shilin Zhao, et al.
Plos One|November 25, 2011
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationInna Y Gong, Ute I Schwarz, Natalie Crown, et al.
BMC Genomics|September 27, 2022
Genome-wide association analyses of common infections in a large practice-based biobankLan Jiang, V Eric Kerchberger, Christian Shaffer, et al.
JAMA Network Open|January 19, 2019
Association Between Low-Density Lipoprotein Cholesterol Levels and Risk for Sepsis Among Patients Admitted to the Hospital With InfectionQiPing Feng, Wei-Qi Wei, Sandip Chaugai, et al.
Pharmacogenetics and Genomics|May 19, 2005
Variation in the alpha2B-adrenergic receptor gene (ADRA2B) and its relationship to vascular response in vivoMordechai Muszkat, Daniel Kurnik, Joseph Solus, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid ArthritisMichelle J Ormseth, Patricia G Yancey, Joseph F Solus, et al.
Arthritis Care & Research|January 3, 2013
Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseasesVivian K Kawai, Carlos G Grijalva, Patrick G Arbogast, et al.
Pageof 28